Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion type Assertion NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_head.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion description "[Because the increased BACE1 activity observed in AD patients does not seem to arise from genetic mutations or polymorphisms in BACE1, the identification of PAR-4 as an endogenous regulator of BACE1 activity may have significant implications for developing novel therapeutic strategies for AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_provenance.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion evidence source_evidence_literature NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_provenance.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion SIO_000772 15671026 NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_provenance.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion wasDerivedFrom befree-2016 NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_provenance.
- NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_assertion wasGeneratedBy ECO_0000203 NP477959.RALgGlIQip-CiewyFy_6rVlBx0yLMCowSBViGkXrfDK14130_provenance.